N
Power Law company profile
Niagen Bioscience
Biotech & Life Sciences · Los Angeles, United States · Founded 1999 Colt
Valuation
$558M
Market cap · 2026
Revenue
$100M
Latest reported FY
EBITDA
$9.2M
Latest reported FY
Featured in
$1B+ revenueColt · Power Law growth-stage
Global footprint
Where Niagen Bioscience has talent and traffic
Web traffic by country
11K
monthly visits
across markets
across markets
🇺🇸 United States128.2%
🇬🇧 United Kingdom15.5%
🇮🇳 India11.8%
🇫🇷 France3.6%
🇨🇦 Canada2.7%
Market sentiment
What the market is saying about Niagen Bioscience
An AI-synthesized read of the highest-engagement posts about Niagen Bioscience on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Niagen Bioscience on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.